152 related articles for article (PubMed ID: 32954379)
1. Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis.
Frisch T; Elkjaer ML; Reynolds R; Michel TM; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
Netw Syst Med; 2020; 3(1):122-129. PubMed ID: 32954379
[No Abstract] [Full Text] [Related]
2. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis.
Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
Acta Neuropathol Commun; 2019 Dec; 7(1):205. PubMed ID: 31829262
[TBL] [Abstract][Full Text] [Related]
3. Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis.
Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
Acta Neuropathol Commun; 2019 Apr; 7(1):58. PubMed ID: 31023379
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions.
Elkjaer ML; Hartebrodt A; Oubounyt M; Weber A; Vitved L; Reynolds R; Thomassen M; Rottger R; Baumbach J; Illes Z
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200213. PubMed ID: 38564686
[TBL] [Abstract][Full Text] [Related]
5. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
[TBL] [Abstract][Full Text] [Related]
6. Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?
Boscia F; Elkjaer ML; Illes Z; Kukley M
Front Cell Neurosci; 2021; 15():685703. PubMed ID: 34276310
[TBL] [Abstract][Full Text] [Related]
7. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
[TBL] [Abstract][Full Text] [Related]
8. The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis.
Holland CM; Charil A; Csapo I; Liptak Z; Ichise M; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
J Neuroimaging; 2012 Apr; 22(2):129-36. PubMed ID: 21447022
[TBL] [Abstract][Full Text] [Related]
9. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
11. Microglia and astroglia proliferation within the normal appearing white matter in histologically active and inactive multiple sclerosis.
Nowacki P; Koziarska D; Masztalewicz M
Folia Neuropathol; 2019; 57(3):249-257. PubMed ID: 31588711
[TBL] [Abstract][Full Text] [Related]
12. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
13. Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain.
Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F; Agresti C
Front Cell Neurosci; 2020; 14():190. PubMed ID: 32733206
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
[TBL] [Abstract][Full Text] [Related]
15. Design and development of an ethnically-diverse imaging informatics-based eFolder system for multiple sclerosis patients.
Ma KC; Fernandez JR; Amezcua L; Lerner A; Shiroishi MS; Liu BJ
Comput Med Imaging Graph; 2015 Dec; 46 Pt 2(Pt 2):257-68. PubMed ID: 26564667
[TBL] [Abstract][Full Text] [Related]
16. Fractal dimension and white matter changes in multiple sclerosis.
Esteban FJ; Sepulcre J; de Mendizábal NV; Goñi J; Navas J; de Miras JR; Bejarano B; Masdeu JC; Villoslada P
Neuroimage; 2007 Jul; 36(3):543-9. PubMed ID: 17499522
[TBL] [Abstract][Full Text] [Related]
17. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.
Vrenken H; Geurts JJ; Knol DL; van Dijk LN; Dattola V; Jasperse B; van Schijndel RA; Polman CH; Castelijns JA; Barkhof F; Pouwels PJ
Radiology; 2006 Sep; 240(3):811-20. PubMed ID: 16868279
[TBL] [Abstract][Full Text] [Related]
18. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
19. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
Moccia M; Quarantelli M; Lanzillo R; Cocozza S; Carotenuto A; Carotenuto B; Alfano B; Prinster A; Triassi M; Nardone A; Palladino R; Brunetti A; Brescia Morra V
Eur J Neurol; 2017 Jan; 24(1):195-204. PubMed ID: 27801535
[TBL] [Abstract][Full Text] [Related]
20. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
